W3W-17574-57550
4 vaccinations
1 coded response
51 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 983 / WA
- Registered
- 2021-06-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
XX3-31550-55352
Child or adolescent in my care · Female · 2021-11-21
ARD-25211-54209
Child or adolescent in my care · Male · 2022-08-03
KWH-66493-76727
Child or adolescent in my care · Male · 2022-08-10
Timeline
-
2021-06-16
Registered in v-safe
-
2021-06-16
Dose 1 — Pfizer-BioNTech
-
2021-06-16
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-06-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-06-18
- 2021-06-19
- 2021-06-21
- 2021-06-22
- 2021-06-23
- 2021-06-30
-
2021-07-07
Dose 2 — Pfizer-BioNTech
- 2021-07-07
-
2021-07-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-07-09
- 2021-07-10
- 2021-07-11
- 2021-07-12
- 2021-07-13
- 2021-07-14
- 2021-07-21
- 2021-07-28
- 2021-08-04
- 2021-08-11
- 2021-08-18
-
2021-10-06
Survey response — 3 months, dose 2MedDRA: Ageusia, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Currently have a cold and loss of taste.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-05
-
2022-02-19
Dose 3 — Pfizer-BioNTech
- 2022-02-19
-
2022-02-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-02-22
- 2022-02-23
- 2022-02-25
- 2022-02-26
- 2022-03-05
- 2022-03-12
- 2022-03-19
- 2022-03-26
- 2022-04-02
- 2022-05-21
- 2022-08-20
-
2022-10-15
Dose 4 — Moderna
-
2022-10-16
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-21
- 2022-10-22
- 2022-10-29
- 2022-11-07
- 2022-11-12
- 2022-11-19
- 2022-11-26
- 2023-01-14
- 2023-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-16 | Pfizer-BioNTech | |
| 2 | 2021-07-07 | Pfizer-BioNTech | No |
| 3 | 2022-02-19 | Pfizer-BioNTech | No |
| 4 | 2022-10-15 | Moderna | No |
Free text
Release 10 — 3 months, dose 2
Symptoms: Currently have a cold and loss of taste.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release